Allows Endovascular Procedure to be Performed from the Cath-Lab Control Room, Potentially Minimizing Radiation Exposure and Reducing Physical Strain for the Healthcare Providers Design Patent ...
Representing a significant advancement in healthcare, endovascular procedures performed inside blood vessels embody the intersection of medicine and technology. By addressing critical conditions such ...
Microbot Medical Inc. MBOT recently received FDA 510(k) clearance for its LIBERTY Endovascular Robotic System, marking a major regulatory milestone for the company. The LIBERTY system is designed to ...
HINGHAM, Mass., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Demonstrating another key achievement, Microbot Medical Inc. (MBOT), continues to execute its objective of expanding its global intellectual property ...
HINGHAM, Mass., June 14, 2017 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq:MBOT), a medical device company specializing in the design and development of transformational micro-robotic medical ...
HINGHAM, Mass., Nov. 18, 2022 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), in a continuation of its efforts to create barriers and expand its global intellectual property portfolio for ...
The future of medicine is going to be hand-delivered — but not by mail carriers. Instead, life-saving drugs will be parceled, smuggled, and transported in the body via tiny, self-propelled microbots.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback